Search Results 1051-1060 of 20170 for Hepatitis C

  1. Valoctocogene roxaparvovec-rvox (intravenous route) - Side effects & uses - Mayo Clinic

    Liver disease (eg, hepatitis B or C, non-alcoholic fatty liver disease, chronic alcohol consumption, and non-alcoholic steatohepatitis)—Use with caution.

  2. Portal hypertension - Doctors and departments - Mayo Clinic

    ... ...a, Cirrhosis, Alcoholic liver disease, Hepatitis C, Hepatitis B, Nonalcoholic fatty liver disease, Primary biliary cholangitis, Liver tumor ...

  3. Biliary Epigenetics and Regenerative Medicine: Robert C. Huebert

    By creating these patient-specific liver cells, the lab can explore the genetic and epigenetic factors underlying biliary cell development and disease. These ...

  4. Gastroenterology and Hepatology - Doctors - Mayo Clinic

    atty liver disease, Cirrhosis, Hepatitis C, Cholangiocarcinoma, Liver cancer, Hepatocellular carcinoma, Gallbladder cancer, Chronic liver disease, Hepatic ...

  5. Pembrolizumab, Lenalidomide, and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma Eligible for Stem Cell Transplant - Mayo Clinic

    Known active hepatitis B (e.g., hepatitis B surface antigen [HBsAg] reactive) or hepatitis C (e.g., hepatitis C virus [HCV] ribonucleic acid [RNA] [qualitative] ...

  6. Surgery - Doctors - Mayo Clinic

    ... Hepatitis C, Hepatitis B, No...nalcoholic fatty liver disease, Primary biliary cholangitis, Cholangiocarcinoma, Primary sclerosing cholangitis, Wilson's ...

  7. Overview - Biliary Epigenetics and Regenerative Medicine: Robert C. Huebert

    By creating these patient-specific liver cells, the lab can explore the genetic and epigenetic factors underlying biliary cell development and disease. These ...

  8. A Platform Study In Non-Small Cell Lung Cancer (NSCLC) - Mayo Clinic

    * Has either a known history of Hepatitis B virus (HBV) or has active Hepatitis C virus (HCV). * Has a history of (non-infectious) pneumonitis that required ...

  9. Phase IIa Study Evaluating Safety and Efficacy of BL-8040 in Relapsed/Refractory AML Patients - Mayo Clinic

    ... C or grade ≥ 2 of neurological toxicity. Seropositive for HIV antibodies (HIV1 and HIV2), Hepatitis C antibody (Hep C Ab) or a Hepatitis B carrier ...

  10. Mayo Clinic Transplant Center - Doctors

    , Hepatitis C, Wilson's disease, Hepatitis B, Hepatocellular carcinoma, Primary biliary cholangitis, Nonalcoholic fatty liver disease, Cirrhosis, Autoimmune ...